Increasing evidence has revealed the multiple roles of long noncoding RNAs (lncRNAs) in neurodevelopment, brain function and aging, and their dysregulation was implicated in many types of neurological diseases. However, expression pattern and diagnostic role of lncRNAs in Alzheimers disease (AD) remain largely unknown and has gained significant attention. In this study, we performed a comparative analysis for lncRNA expression profiles in four brain regions in brain aging and AD. Our analysis revealed age- and disease-dependent region-specific lncRNA expression patterns in aging and AD. Moreover, we identified a panel of nine lncRNAs (termed LncSigAD9) in a discovery cohort of 114 samples using supervised machine learning and stepwise selection method. The LncSigAD9 was able to differentiate between AD and healthy controls with high diagnostic sensitivity and specificity both in the discovery cohort (86.3 and 89.5%) and the additional independent AD cohort (90.8 and 83.8%). The receiver operating characteristic curves for the LncSigAD9 were 0.863 and 0.939 for discovery and independent cohorts, respectively. Furthermore, the LncSigAD9 demonstrated higher diagnostic performance than nine-minus-one lncRNA signature and mRNA-based signature with a similar number of genes. In silico functional analysis indicated the involvement of lncRNA expression variation in brain development- and metabolism-related biological processes. Taken together, our study highlights the importance of lncRNAs in brain aging and AD, and demonstrated the utility of lncRNAs as a promising biomarker for early AD diagnosis and treatment.